Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43,056,667
-
Total 13F shares
-
22,517,975
-
Share change
-
+22,517,875
-
Total reported value
-
$698,109,449
-
Price per share
-
$31.02
-
Number of holders
-
47
-
Value change
-
+$698,106,449
-
Number of buys
-
46
Institutional Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q2 2020
As of 30 Jun 2020,
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,517,975 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MPM ASSET MANAGEMENT LLC, FMR LLC, CHI Advisors LLC, MPM Oncology Impact Management LP, Redmile Group, LLC, BVF INC/IL, Logos Global Management LP, Artal Group S.A., and RA CAPITAL MANAGEMENT, L.P..
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.